Which laboratory tests should be ordered for a patient presenting with chest pain and shortness of breath?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 19, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question

Blood Tests for Chest Pain and Shortness of Breath

For patients presenting with chest pain and shortness of breath, order serial troponin (high-sensitivity troponin at 0 and 1-3 hours, or conventional troponin at 0 and 3-6 hours) as the primary blood test to exclude myocardial injury, with consideration for B-type natriuretic peptide (BNP) if heart failure is suspected based on clinical findings like elevated jugular venous pressure. 1

Risk Stratification Drives Testing Strategy

The 2021 AHA/ACC guideline emphasizes that testing should be selective and risk-stratified rather than reflexive 1. The approach depends on your initial assessment:

High-Risk Patients

  • Immediate action: These patients bypass blood testing and proceed directly to invasive coronary angiography 1
  • Blood tests here serve to confirm diagnosis, not guide initial management

Intermediate-Risk Patients

  • Serial troponin measurements are the cornerstone:

    • High-sensitivity troponin: Draw at presentation (time zero) and repeat at 1-3 hours 1
    • Conventional troponin: Draw at presentation and repeat at 3-6 hours 1
    • This protocol has 96% sensitivity for acute myocardial infarction 2

  • CK-MB mass can supplement troponin but is less specific for cardiac injury 3

    • Useful for ruling out clinical MI (96% sensitivity) but misses myocyte necrosis without infarction 2

Low-Risk Patients (<1% 30-day MACE risk)

  • Single high-sensitivity troponin below the limit of detection at presentation is reasonable to exclude myocardial injury if symptoms began ≥3 hours before arrival 1
  • These patients can be discharged without urgent testing 1

Additional Blood Tests Based on Clinical Presentation

For Suspected Heart Failure

When you observe elevated jugular venous pressure or other signs of volume overload:

  • B-type natriuretic peptide (BNP) provides diagnostic and prognostic information for heart failure 4
  • This is particularly relevant when shortness of breath is the predominant symptom

For Suspected Pulmonary Embolism

If clinical risk stratification (Wells criteria) suggests PE:

  • D-dimer for low or intermediate risk patients 5, 6
  • High-risk patients proceed directly to imaging 5

Critical Implementation Details

Standardize your institutional protocol based on your specific troponin assay 1. The timing intervals differ significantly between high-sensitivity and conventional assays, and mixing protocols leads to missed diagnoses.

Beware of false positives: Heterophilic antibodies can cause grossly elevated troponin levels (>10,000 ng/L) without actual cardiac injury 7. If troponin results seem discordant with clinical presentation, involve your laboratory medicine team to investigate potential interference.

Troponin threshold matters: Using a lower threshold (0.03 ng/ml) for troponin T improves sensitivity to 90% for myocyte necrosis compared to 63% with CK-MB mass 2. This is crucial for detecting unstable angina with minor myocardial damage.

What NOT to Order Routinely

  • Serial ECG/ST segment monitoring adds minimal diagnostic value beyond the initial ECG in patients with normal or non-diagnostic findings 2
  • Lactate dehydrogenase (LD-1) has been displaced by cardiac-specific troponins and should not be used 3
  • Myoglobin alone is not cardiac-specific and requires supplementation with troponins; it adds complexity without improving outcomes in most protocols 3

The Algorithmic Approach

  1. Obtain 12-lead ECG immediately (not a blood test but essential for risk stratification)
  2. Draw initial troponin at presentation
  3. Risk stratify using clinical decision pathways
  4. If intermediate risk: Repeat troponin at 1-3 hours (high-sensitivity) or 3-6 hours (conventional)
  5. If low risk with symptoms >3 hours ago: Single high-sensitivity troponin below detection limit is sufficient
  6. Add BNP if heart failure suspected clinically
  7. Add D-dimer only if PE is in differential and patient is low-to-intermediate risk by Wells criteria

The key pitfall is ordering excessive or poorly timed tests—the guideline explicitly recommends against layered testing when diagnostic yield is low 1. Focus your testing based on risk stratification rather than ordering everything reflexively.

References

3
Research

Laboratory diagnosis of patients with acute chest pain.

Clinical chemistry and laboratory medicine, 2000

6
Research

Outpatient diagnosis of acute chest pain in adults.

American family physician, 2013

7
Research

A Diagnostic Dilemma from a Presentation of Shortness of Breath and Chest Pain.

The journal of applied laboratory medicine, 2022

Related Questions

In an otherwise healthy 20-year-old presenting with chest pain evaluated as an outpatient, which laboratory tests should be ordered?
In a 42-year-old man with chest pain worsened by deep breathing, chest wall tenderness, and palpitations, what is the appropriate diagnostic workup and initial management?
Should a 55‑year‑old woman with chest pressure radiating to the neck, diaphoresis, persistent mild chest pain, and tachycardia be sent to the emergency department for urgent cardiac evaluation?
In a 23-year-old male with two days of right-sided chest wall pain that worsens with coughing and deep breathing and normal vital signs, how should I evaluate and manage him?
For a 62-year-old woman with no cardiac history who presents with left-sided chest pain, shortness of breath, and orthostatic dizziness, what immediate outpatient laboratory tests and imaging should be ordered in addition to a cardiology referral?
I have had nightly fevers for nine days with body aches, headache, light‑headedness and dizziness; prior evaluation for neck stiffness was negative for COVID‑19, influenza, respiratory syncytial virus (RSV), and Kernig and Brudzinski signs were absent. What are the possible differential diagnoses and recommended follow‑up treatment plan?
How should a 4-year-old child with a urinary tract infection and balanitis be treated?
What is the recommended dosing, screening, and safety monitoring for Skyrizi (risankizumab) in an adult with moderate-to-severe plaque psoriasis who has failed conventional systemic therapy?
What does a nurse practitioner need to know about the evaluation and management of psoriasis?
What is the evidence supporting the use of the Guardian helmet to reduce head injuries in football players?
Can a patient with type 2 diabetes mellitus who is taking pioglitazone safely start tirzepatide (Mounjaro), and what dosing and monitoring recommendations apply?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.